Drugmaker Bristol-Myers gains after Starboard Value takes stake
Bloomberg Shares of drugmaker Bristol-Myers Squibb Co. gained, with acquisition target Celgene Corp. falling after activist hedge fund Starboard Value was said to have taken a stake in Bristol-Myers. The size of Starboard’s stake and any plans that Jeff Smith’s hedge fund might have for its investment in the $81 billion drugmaker couldn’t immediately be learned when Bloomberg reported the ...
Read More »